13F HOLDINGS REPORT
5AM Venture Management, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001799883-25-000002
Total Value
$273.0M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SKYE BIOSCIENCE INC | SKYE | 9,681,763 | $38.0M | 13.94% |
| 2 | ENTRADA THERAPEUTICS INC | TRDA | 4,256,379 | $24.7M | 9.04% |
| 3 | PHARVARIS N V | PHVS | 797,600 | $19.9M | 7.29% |
| 4 | CAMP4 THERAPEUTICS CORP | CAMP | 5,869,091 | $17.6M | 6.45% |
| 5 | CENTESSA PHARMACEUTICALS PLC | CNTA | 680,945 | $16.5M | 6.05% |
| 6 | VIRIDIAN THERAPEUTICS INC | VRDN | 736,595 | $15.9M | 5.82% |
| 7 | ENLIVEN THERAPEUTICS INC | ELVN | 772,477 | $15.8M | 5.79% |
| 8 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,050,000 | $15.0M | 5.48% |
| 9 | DIANTHUS THERAPEUTICS INC | DNTH | 365,053 | $14.4M | 5.26% |
| 10 | TYRA BIOSCIENCES INC | TYRA | 939,298 | $13.1M | 4.81% |
| 11 | CELLDEX THERAPEUTICS INC NEW | CLDX | 497,270 | $12.9M | 4.71% |
| 12 | ERASCA INC | ERAS | 5,405,404 | $11.8M | 4.32% |
| 13 | PRAXIS PRECISION MEDICINES I | PRAX | 170,000 | $9.0M | 3.30% |
| 14 | GH RESEARCH PLC | GHRS | 572,665 | $8.2M | 3.00% |
| 15 | TECTONIC THERAPEUTIC INC | TECX | 511,660 | $8.0M | 2.94% |
| 16 | BIOHAVEN LTD | BHVN | 478,972 | $7.2M | 2.63% |
| 17 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 2,353,304 | $6.8M | 2.47% |
| 18 | SURROZEN INC | SRZNW | 310,000 | $4.0M | 1.46% |
| 19 | PROTARA THERAPEUTICS INC | TARA | 800,000 | $3.5M | 1.27% |
| 20 | ALECTOR INC | ALEC | 995,841 | $2.9M | 1.08% |
| 21 | SILENCE THERAPEUTICS PLC | SLNCF | 476,200 | $2.5M | 0.91% |
| 22 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 541,666 | $2.5M | 0.90% |
| 23 | RALLYBIO CORP | RLYB | 3,630,724 | $1.8M | 0.66% |
| 24 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 490,000 | $739,900 | 0.27% |
| 25 | MERSANA THERAPEUTICS INC | 59045L205 | 52,200 | $405,072 | 0.15% |